Clinical Trials Directory

Trials / Completed

CompletedNCT05470751

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
ConvaTec Inc. · Industry
Sex
Male
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Male self catherterisng observational study.

Detailed description

This is a multicentre, prospective international observational study. Male patients in the UK, USA and France performing self-catheterisation will be asked to participate in this study. The subjects will be asked to use the GentleCath™ Intermittent Catheter with FeelClean™ Technology as per their normal routine. They will be asked to record when and where they catheterise. At the baseline, during and on completion of the study, the subjects will be asked to complete Difficulty in Catheterisation plus Intermittent Catheter related Quality of Life Questionnaires. Difficulty during catheterisation and quality of life will be assessed using the ICDQ and ISC-Q validated questionnaires during catheterisation at the start of the study before use of GentleCath™ Air has commenced (D0) and on day 1 (D1), day 15 (D15), day 30 (D30), day 45 (D45) and day 60 (D60) transcribed in a collecting record provided for this purpose. Compliance and catheter use will also be assessed. Patient confidence regarding reduced stickiness plus related risk of urethral injury and resultant bleeding or infection will also be recorded.

Conditions

Interventions

TypeNameDescription
DEVICEIntermittent self-catheterisationSelf-catheterising with GC Male and Glide Male with Feelclean technology

Timeline

Start date
2023-02-02
Primary completion
2024-04-06
Completion
2024-04-06
First posted
2022-07-22
Last updated
2024-04-30

Locations

16 sites across 3 countries: United States, France, United Kingdom

Source: ClinicalTrials.gov record NCT05470751. Inclusion in this directory is not an endorsement.